NKK-20936-57856
2 vaccinations
6 coded responses
19 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 790 / TX
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Moderna
- 2020-12-28
-
2020-12-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · NauseaAdult check-in
- 2020-12-30
-
2020-12-31
Survey response — days 1–6 daily, dose 1MedDRA: Dry skin, Erythema — Feeling: FairFree text: A few dry patches with redness around themMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-03
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Oropharyngeal pain — Feeling: Fair · Rash, not including the immediate area around the injection siteFree text: Sore throat with a mild dry coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-04
Survey response — day 7, dose 1MedDRA: Cough, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Rash, not including the immediate area around the injection siteFree text: Sore throat, cough, congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-11
-
2021-01-20
Survey response — day 21, dose 1MedDRA: Oropharyngeal pain — Feeling: FairFree text: Persistent sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-25
Dose 2 — Moderna
- 2021-02-01
- 2021-02-08
-
2021-02-17
Survey response — day 21, dose 2MedDRA: Feeling abnormal — Feeling: GoodFree text: Brain fogMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-04-26
- 2021-07-28
-
2022-01-27
Survey response — 12 months, dose 2MedDRA: COVID-19, Diarrhoea, Dizziness, Nasopharyngitis, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Positive Covid on 1/10/22, Severe diarrhea and vomiting on 1/13-15/22 1/16,17/22 dizziness and lightheaded Currently have head cold symptomsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna | |
| 2 | 2021-01-25 | Moderna |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): A few dry patches with redness around them
Systemic reaction (other): Sore throat with a mild dry cough
Release 1 — day 7, dose 1
Systemic reaction (other): Sore throat, cough, congestion
Release 2 — day 21, dose 1
Symptoms: Persistent sore throat
Release 4 — day 21, dose 2
Symptoms: Brain fog
Release 11 — 12 months, dose 2
Symptoms: Positive Covid on 1/10/22, Severe diarrhea and vomiting on 1/13-15/22 1/16,17/22 dizziness and lightheaded Currently have head cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Feeling abnormal | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Dry skin | ✓ | ✓ | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release